MODD

+ Watchlist + Portfolio

Modular Medical, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $3.32
52-Week Range: $1.72 – $30.00
Market Cap: $18.57M
P/E (TTM): —
EPS (TTM): -9.85
Dividend Yield: —

Advanced Metrics

Price/Book: 1.23
PEG Ratio: —
Return on Equity: -188.05%
Return on Assets: -102.63%
Gross Margin: 0.00%
Operating Margin: 0.00%
Profit Margin: 0.00%
Current Ratio: 4.03
Debt/Equity: 0.03
Total Debt: $393.00K
Free Cash Flow: $-17.24M
Revenue Growth: —
Earnings Growth: —
Enterprise Value: $6.93M

MODD Income statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Revenue	$0.00	$0.00	$0.00	$0.00
Research & Development	$9.06M	$12.88M	$14.70M	$19.97M
Selling, General & Admin	$4.82M	$4.65M	$4.35M	$7.59M
Operating Expenses	$13.88M	$17.53M	$19.05M	$27.56M
Operating Income	-$13.88M	-$17.53M	-$19.05M	-$27.56M
EBITDA	-$13.73M	-$17.10M	-$17.98M	-$25.89M
Pretax Income	-$13.88M	-$17.47M	-$18.82M	-$28.24M
Income Tax	$2.00K	$2.00K	$2.00K	$2.00K
Net Income	-$13.88M	-$17.47M	-$18.82M	-$28.24M
Diluted EPS	-34.50	-23.40	-15.26	—
Diluted Shares	403433	745899	1.23M	—

MODD Balance Sheet statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Cash & Equivalents	$3.80M	$9.23M	$13.10M	$6.94M
Receivables	$5.00K	$147.00K	$70.00K	$17.00K
Current Assets	$4.05M	$9.70M	$13.52M	$7.54M
Total Assets	$7.25M	$13.81M	$18.73M	$14.83M
Current Liabilities	$979.00K	$1.46M	$1.26M	$1.87M
Total Debt	$1.54M	$1.19M	$816.00K	$393.00K
Total Liabilities	$2.17M	$2.27M	$1.66M	$1.87M
Retained Earnings	-$48.46M	-$65.93M	-$84.75M	-$113.00M
Shareholders' Equity	$5.08M	$11.54M	$17.08M	$12.96M
Working Capital	$3.07M	$8.24M	$12.25M	$5.67M

MODD Cash Flow statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Operating Cash Flow	-$11.01M	-$13.95M	-$15.72M	-$23.75M
Capital Expenditure	-$1.64M	-$1.70M	-$2.49M	-$3.93M
Free Cash Flow	-$12.65M	-$15.65M	-$18.21M	-$27.68M
Depreciation & Amortisation	$152.00K	$426.00K	$1.06M	$1.67M
Stock-Based Compensation	$2.72M	$2.70M	$2.38M	$1.78M
Investing Cash Flow	-$1.64M	-$1.70M	-$2.49M	-$3.93M
Financing Cash Flow	$7.37M	$21.09M	$22.08M	$21.53M
Net Change in Cash	-$5.28M	$5.43M	$3.86M	-$6.15M

MODD Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Research & Development	$3.94M	$5.13M	$5.59M	$5.41M	$3.84M
Selling, General & Admin	$1.04M	$1.67M	$2.24M	$1.84M	$1.84M
Operating Expenses	$4.98M	$6.80M	$7.83M	$7.24M	$5.68M
Operating Income	-$4.98M	-$6.80M	-$7.83M	-$7.24M	-$5.68M
EBITDA	-$4.65M	-$6.39M	-$7.44M	-$6.81M	-$5.24M
Pretax Income	-$4.93M	-$6.70M	-$7.79M	-$7.36M	-$6.39M
Income Tax	$0.00	—	$2.00K	$0.00	$0.00
Net Income	-$4.93M	-$6.70M	-$7.79M	-$7.36M	-$6.39M
Diluted EPS	—	-3.60	-4.20	-3.30	—
Diluted Shares	—	1.81M	1.85M	2.20M	—

MODD Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$13.10M	$7.52M	$5.32M	$2.94M	$6.94M
Receivables	$70.00K	$77.00K	$25.00K	$13.00K	$17.00K
Current Assets	$13.52M	$8.29M	$5.95M	$3.47M	$7.54M
Total Assets	—	—	—	$10.26M	$14.83M
Current Liabilities	$1.26M	$2.05M	$4.04M	$2.18M	$1.87M
Total Debt	$816.00K	$715.00K	$611.00K	$504.00K	$393.00K
Total Liabilities	$1.66M	$2.33M	$4.21M	$4.38M	$1.87M
Retained Earnings	-$84.75M	-$91.45M	-$99.25M	-$106.61M	-$113.00M
Shareholders' Equity	$17.08M	$11.84M	$8.77M	$5.88M	$12.96M
Working Capital	$12.25M	$6.24M	$1.90M	$1.29M	$5.67M

MODD Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$4.31M	-$5.37M	-$5.41M	-$7.16M	-$5.82M
Capital Expenditure	-$948.00K	-$934.00K	-$771.00K	-$1.22M	-$1.00M
Free Cash Flow	-$5.26M	-$6.31M	-$6.18M	-$8.38M	-$6.82M
Depreciation & Amortisation	$326.00K	$410.00K	$391.00K	$430.00K	$441.00K
Stock-Based Compensation	$374.00K	$724.00K	$813.00K	$534.00K	-$293.00K
Investing Cash Flow	-$948.00K	-$934.00K	-$771.00K	-$1.22M	-$1.00M
Financing Cash Flow	$11.37M	$733.00K	$3.98M	$6.00M	$10.82M
Net Change in Cash	$6.11M	-$5.57M	-$2.21M	-$2.38M	$4.00M

Market Snapshot

About

Modular Medical develops insulin delivery systems and medical devices for diabetes management. The company focuses on creating innovative, user-friendly solutions to improve patient outcomes and quality of life for people with diabetes.